Activation of the NF-kB transcription factors has been shown to be directly in¯uenced by changes in the microtubule cytoskeleton network. To better understand cytoskeletal regulation of NF-kB, experiments were performed to determine whether the microtubule (MT) stabilizing agent taxol could modulate NF-kB activation in the presence of dierent NF-kB inducers. Pretreatment of murine NIH3T3 and human 293 cells with 5 mM taxol resulted in complete inhibition of phorbol, 12-myristate, 13-acetate (PMA) mediated NF-kB activation, detected as the loss of DNA binding and reduced NF-kB dependent reporter gene activity. Furthermore, in COS-7 and NIH3T3 cells, PMA-induced IkBa turnover was dramatically reduced in taxol treated cells, mediated via the inhibition of IkBa phosphorylation. However, taxol did not prevent TNF-a induced IkBa phosphorylation, degradation, or NF-kB activation, indicating that TNF-a acts through a microtubule-independent pathway. In vitro kinase assays with PMA stimulated cell extracts demonstrated that taxol reduced protein kinase C activity by 30%, thus implicating the loss of PKC activity as a possible regulatory target of taxol-mediated suppression of NF-kB. Since PMA causes modulation of cytoarchitecture through PKC activation, microtubule integrity and cell morphology was analysed by indirect immuno¯uorescence. Both PMA and nocodazole, a MT depolymerizing agent, caused microtubule depolymerization, whereas TNF-a did not alter MT integrity; concomitant taxol treatment blocked both nocodazole and PMA induced depolymerization of MTs, as well as NF-kB induction, thus demonstrating a link between microtubule depolymerization and NF-kB activation. These observations illustrate a novel biological activity of taxol as a selective inhibitor of NF-kB activity, suggesting a link between the state of microtubule integrity and gene regulation.
Introduction
A growing body of evidence has reinforced the idea that the cytoskeleton has the potential to regulate gene activation through a complex regulatory process involving structural cues in the cytoskeletal matrix and the eective balance of numerous populations of cytoskeletal-associated proteins (Forgacs, 1995; Hughes, 1995; Manie et al., 1993; Tsukita and Yonemura, 1997; Reszka et al., 1995) . The transmission of information from the plasma membrane to the nucleus is associated with a number of rapid changes in cell physiology. With regard to cytoskeletal regulation of signaling pathways, phorbol ester signaling is an important modulator of cytoskeletal dynamics (Alexandrova et al., 1993; Bouron, 1997; Dwyer-Nield et al., 1996; Mangoura et al., 1995; Melamed et al., 1995; Moore et al., 1995) .
The biological properties of phorbol esters are derived from their ability to mimic the responses of diacylglycerol (DAG) allowing direct activation of protein kinase C (PKC) (Basu et al., 1996) . Activated PKC is subsequently recruited to the membrane where it is believed to interact with the cytoskeleton (Goodnight et al., 1995) . PKC substrates include numerous cytoskeletal proteins such as vimentin, talin, and MAPKs (Mangoura et al., 1995; Schonwesser et al., 1998; Seuerlein and Rozengurt, 1996) . The most dramatic eect of PMA on PKCs is the tremendous morphological change observed in many cell populations. PMA is involved directly or indirectly with the regulation of focal adhesion formation (Kawasugi et al., 1995) , actin polymerization (DwyerNield et al., 1996; Niu and Nachmias, 1994) , dierentiation of numerous cell types (Dwyer-Nield et al., 1996; de Vente et al., 1995; McGowan et al., 1996) , embryonic development (Mangoura et al., 1995; Moore et al., 1995) , cellular transport (Alexandrova et al., 1993; Debal et al., 1997) , and NF-kB activation Bitar et al., 1995; Rosette and Karin, 1995; Wesselborg et al., 1997) all of which depend on the direct activation of PKC by PMA. In the case of NF-kB, PKC-z appears to be the major upstream regulator in PMA stimulation Fogueira et al., 1996; Muller et al., 1995; Sontag et al., 1997) . Given the relationship between PKC activation and control of various morphogenetic processes, it is likely that cytoskeletal regulation of PKC maybe an integral component of NF-kB activation.
NF-kB is a ubiquitously expressed family of transcriptions factors activated in response to a wide variety of inducers such as in¯ammatory cytokines, phorbol esters, virus infection, and lipopolysaccharride (for review, see Beauparlant and Hiscott, 1996; Baltimore, 1988, 1996; Baeuerle and Henkel, 1994) . Induction of NF-kB is tightly regulated by the ankyrin repeat containing inhibitory IkB proteins (Baeuerle and Baltimore, 1996) . Upon stimulation, inducible phosphorylation of IkBa occurs at Ser32 and Ser36, resulting in subsequent degradation through the ubiquitin-dependent 26S proteasome complex Henkel et al., 1993; Lin et al., 1995) . Degradation of IkB exposes the nuclear localization signal of NF-kB, allowing translocation to the nucleus and transactivation of many NFkB speci®c genes. A unique characteristic of NF-kB is that in unstimulated cells, NF-kB is localized in the cytoplasm in association with IkBa, a portion of which is complexed with the microtubule cytoskeleton (Crepieux et al., 1997) . This interaction has been shown to be mediated in part through a coupling of the N-terminal response domain of IkBa and the dynein light chain subunit of the dynein motor protein. NF-kB activation is also sensitive to the polymerization state of the microtubule cytoskeleton (Rosette and Karin, 1995) . Various depolymerizing agents such as colchicine and nocodazole induce rapid transactivation of NF-kB through phosphorylation and degradation of IkBa. However, it is not apparent whether the depolymerizing event is sucient to activate NF-kB or whether these agents activate a kinase(s).
Taxol is a novel antineoplastic agent with proven ecacy in the treatment of breast, ovarian, lung, and colon cancers (Haldar et al., 1996; Wani et al., 1971; Lee et al., 1997) . Taxol blocks cells at the G2/M junction of the cell cycle (Blagosklonny et al., 1996) by stabilizing microtubules against depolymerization (Arnal and Wade, 1995) . Taxol is believed to stabilize microtubules through its interaction with the Nterminal region of b-tubulin subunits, thus blocking a GTP-dependent step involved in microtubule shrinkage (Hyman et al., 1992) . Taxol is able to exert both a microtubule stabilizing eect and a cytotoxic response, suggesting a dichotomy in the ability of taxol to act either as an activator or repressor of numerous signaling pathways (Basu et al., 1996; Lee et al., 1997; Singh and Aggarwal, 1995) .
In the present study, we demonstrate that taxol selectively inhibits phorbol ester-induced NF-kB activation via inhibition of IkBa phosphorylation and subsequent degradation. Furthermore, PMA induced PKC activity was partially inhibited by taxol. PMAinduced microtubule depolymerization was also blocked in the presence of taxol, establishing the importance of microtubule depolymerization in PMA induced NF-kB activation.
Results

Taxol speci®cally suppresses PMA-induced NF-kB activation
Previous studies have established that the major antineoplastic eect of taxol is directly linked to its ability to stabilize microtubule structure and arrest cells in the G2/M phase of the cell cycle (Arnal and Wade, 1995) . To understand the relationship between microtubule stability and NF-kB dependent gene activity, experiments were performed to determine if taxol could alter NF-kB induction in ®broblastic cells. Nuclear extracts were prepared from PMA or TNF-a induced murine NIH3T3, human 293 cells and primate COS-7 cells in the presence or absence of taxol and examined for NF-kB-binding activity by mobility shift assay, using the PRD II domain of the IFN-b promoter (Garoufalis et al., 1994) . Pretreatment with taxol for 30 min selectively inhibited PMA induced NF-kB activation, measured at 1, 2 or 4 h after addition of inducer ( Figure 1a , lanes 9 ± 14) but did not block TNF-a stimulated NF-kB DNA binding (Figure 1a , lanes 3 ± 8) in NIH3T3 cells. The kinetics of the taxol eect were also determined after simultaneous addition of PMA and taxol (Figure 1b) . Interestingly, taxol eectively blocked PMA stimulation as early as 15 min and maintained its suppressive eects as late as 4 hours (Figure 1b, lanes 9 ± 14) . Comparison of Figure 1a and b suggests that pretreatment or simultaneous treatment with taxol had similar inhibitory eects on PMA induction. To further characterize the nature of the NF-kB-DNA complexes generated after PMA induction, speci®c antibodies directed against either RelA (p65), p50/p105, or c-Rel were used in a supershift assay to determine the subunit composition of the NFkB complexes (Figure 1c ). The major NF-kB subunit identi®ed was RelA (p65) (Figure 1c lane 4) , including p50 and to a lesser extent c-Rel (Figure 1c , lanes 3 and 5 respectively). The intensity of unshifted NF-kB complexes corresponding to p50 was reduced approximately threefold as compared to control (compare lanes 1 and 3). Analysis of p65 shifted complexes (upper arrow) indicated a 20-fold increase in intensity in comparison to c-Rel shifted complexes. The relative excess of p65 over p50 and c-Rel, suggests that PMA induction of NF-kB recruits predominantly p65 homodimers, a moderate level of p65/p50 heterodimers and to a lesser extent p65/c-Rel heterodimers. The inhibitory eect of taxol on NF-kB DNA binding was con®rmed in human 293 cells (Figure 1d ). Comparable to NIH3T3 cells, PMA stimulation of NF-kB DNA binding was inhibited by taxol ( Figure 1d , lanes 9 ± 14), but again no suppressive eect was observed after TNF-a stimulation (Figure 1d , lanes 3 ± 8). Similar results were also obtained in COS-7 cells (data not shown). The selective capacity of taxol to block PMA induced NF-kB binding illustrates an interesting divergence in the signaling pathways leading to NFkB activation.
Taxol suppresses NF-kB speci®c gene activation NF-kB dependent gene activity was analysed by cotransfection, using the HIV enhancer CAT reporter or the mutated HIV enhancer CAT plasmid in 3T3 and 293 cells (Figure 2) . In NIH3T3 cells, TNF-a stimulation increased reporter gene expression by sevenfold (Figure 2a , lanes 3 ± 5; dark columns), while TNF-a in the presence of taxol increased gene expression up to tenfold. The inducibility of the reporter gene was lower after PMA addition ( Figure  2a , lanes 9 ± 11), with a fourfold level of induction. Consistent with the EMSA data, the level of NF-kB dependent reporter gene activity was repressed in PMA stimulated cells pretreated with taxol ( Figure 2a , lanes 12 ± 14) to levels comparable to the controls. Similar results were also obtained using 293 cells with a 14-fold stimulation after TNF-a addition (Figure 2b . Finally, to determine that the NF-kB sites in the promoter region were indeed required for expression, the mutated HIV enhancer CAT plasmid was analysed under similar conditions ( Figure 2a and b, light columns). The level of CAT inducibility using the mutated plasmid did not exceed that of untreated controls, demonstrating that a functional NF-kB binding site was required for NF-kB dependent reporter gene expression.
Taxol modulates PKC activity
As in vitro kinase assay was next used to measure PMA-induced activation of PKC, an essential downstream eector of PMA signaling. Whole cell extracts from PMA treated 3T3 cells were incubated with a peptide fragment corresponding to the EGF receptor (KRTLRR), a substrate for PKC (Figure 3 ). In the case of PMA treated cells, PKC activity reached a fourfold maximum induction between 1 ± 4 min. In cells pre-treated with taxol and PMA, the maximum induction was approximately 1.5-fold lower than that of cells treated without taxol. Thus, the inhibitory eects of taxol may block NF-kB activation by suppressing PMA-induced PKC activity. Since TNF-a is not a conventional activator of PKC, the basal level of PKC activity was unchanged in the presence of TNF-a regardless of whether taxol was present or not.
PMA induced microtubule depolymerization
Since taxol suppressed PMA-induced PKC activity and NF-kB induction, the capacity of PMA to produce changes in microtubule architecture and the potential eect of taxol on these structural changes was next analysed (Figure 4 ) in COS-7 cells. Taxol did not cause major structural changes in the tubulin network as compared to untreated cells (Figure 4a and b). As a positive control, nocodazole, a reversible inhibitor of tubulin polymerization (De Brabander et al., 1976 ) was used to demonstrate breakdown of the microtubule network ( Figure 4c ); as expected, taxol was able to prevent tubulin depolymerization in nocodazole treated cells (Figure 4d ). PMA treatment also induced microtubule depolymerization (Figure 4e ). Two major Figure 1 Eect of taxol on inducer mediated activation of NF-kB. (a) NIH3T3 cells were treated with 10 ng/ml TNF-a, or 100 ng/ ml PMA for the indicated times in the presence (lanes 2, 6 ± 8, 12 ± 14) or absence (lanes 1, 3 ± 5, 9 ± 11) of 5 mM taxol. EMSA was performed on nuclear extracts (5 mg). (b) A similar experiment was performed to measure a shorter time course for PMA inducible NF-kB DNA binding. Cells were treated with PMA alone (lanes 1, 3 ± 8) or simultaneously with 5 mM taxol (lanes 2, 9 ± 14). (c) Subunit characterization of PMA induced NF-kB-DNA complexes. Nuclear extracts from NIH3T3 induced for 4 h with PMA were incubated with speci®c antibodies recognizing the NF-kB subunits p50 (lane 3), RelA(p65) (lane 4), and c-Rel (lane 5). The lower arrows indicates NF-kB speci®c complexes and the upper arrows indicate the antibody shifted complexes. (d) 293 cells were treated with 10 ng/ml TNF-a, or 100 ng/ml PMA for the indicated times in the presence (lanes 2, 6 ± 8 and 12 ± 14) or absence (lanes 1, 3 ± 5, 9 ± 11) of 5 mM taxol. EMSA was performed on nuclear extracts (5 mg). The speci®city of the band corresponding to NF-kB was determined using a 125 M excess of unlabeled cold DNA probe as speci®c competitor (lane 15 in a, b and d) morphologies were present in PMA treated cells: (1) most cells displayed a homogeneous breakdown in microtubule ®laments similar to that seen in nocodazole treated cells ( Figure 4c) ; and (2) cells displaying an intact microtubule network exhibited extended membrane projections not present in control cells. In contrast, cells treated with taxol prior to PMA induction exhibited a normal morphology and intact microtubules (Figure 4f ). These results are consistent with the possibility that taxol suppresses PMA-induced NF-kB induction by blocking PKC activation and inhibiting subsequent changes in microtubule structure.
Taxol suppresses IkBa phosphorylation and degradation
Inducible phosphorylation and ubiquitin dependent, proteasome mediated degradation of IkBa precede NFkB translocation to the nucleus and DNA binding (Cordle et al., 1993; Brown et al., 1993; Rice and Ernst, 1993) . Phosphorylation of IkBa on Ser32 and Ser36 is the critical event controlling downstream proteolytic degradation of IkBa (Traenckner et al., 1994; Sun et al., 1996; . We next sought to examine the eect of taxol on IkBa phosphorylation state following TNF-a or PMA induction. In this experiment, the proteasome inhibitor MG132 was used to block IkBa degradation and permit the accumulation and detection of phosphorylated IkBa (Figure 5a ). After immunoblotting with IkBa speci®c antibodies (MAD10B), phosphorylated IkBa was identi®ed as a slower migrating species just above unphosphorylated IkBa. As early as 15 min after stimulation, IkBa phosphorylation was detected in both TNF-a and PMA treated cells ( Figure  5a , bottom lanes 3 ± 5 and 9 ± 11). Strikingly, taxol pretreatment selectively inhibited accumulation of phosphorylated IkBa in PMA treated cells ( Figure  5a , bottom lanes 12 ± 14) while cells treated with TNFa were unaected by taxol (Figure 5a , lanes 6 ± 8). Clearly, taxol inhibited PMA-but not TNF-induced phosphorylation of IkBa. To con®rm that the slower migrating IkBa species was indeed phosphorylated at the N-terminus, a phosphoserine 32-speci®c antibody was used to detect phosphorylated IkBa (Figure 5a ; top). As expected, S32 speci®c phosphorylation was not detected for taxol treated cells (Figure 5a ; top lane 2) nor cells treated with taxol in the presence of PMA (Figure 5a ; top lanes 12 ± 14).
To determine whether taxol aected PMA induced IkBa turnover, COS-7 cells were pretreated with cycloheximide to block de novo IkBa synthesis and (Figure 5b) . By immunoblot analysis of IkBa levels, compared to an actin control, PMA induction resulted in rapid IkBa degradation; within 15 min, endogenous IkBa levels were reduced more than 60% ( Figure 5, lane 3) . By 2 h after induction, IkBa protein was barely detectable in PMA treated cells (Figure 5b, lane 6) . However, taxol treated cells showed no evidence of induced degradation in the presence of PMA (Figure 5b, lanes 7 ± 10) . In separate experiments, TNF-a induced degradation of IkBa was not inhibited by the addition of taxol (data not shown). Similar results were also obtained in NIH3T3 (Figure 5c and d) . Furthermore, phosphoserine-32 IkBa was detected in TNF-a and PMA stimulated NIH3T3 cells (Figure 5c , lanes 3 ± 8 and 9 ± 11 respectively) but not in taxol treated cells stimulated with PMA (Figure 5c, lanes 12 ± 14) and then plateaus; degradation is complete by 2 h. Previous ®ndings have also established that PMA induced turnover of IkBa displays a slower rate of degradation in comparison to other inducers such as TNF-a or IL-1 (Brown et al., 1993; DiDonato et al., 1995) . These experiments establish that the ability of taxol to inhibit PMA-induced NF-kB DNA binding correlates directly with IkBa phosphorylation and degradation.
Discussion
The objective of the present study was to investigate whether taxol could speci®cally interrupt NF-kB activation by interfering with microtubule depolymerization and signaling pathways that may be linked physically and/or functionally with the microtubule cytoskeleton. Our results demonstrate that: (1) taxol eectively inhibited NF-kB DNA binding activity in PMA induced cells but not in TNF-a stimulated cells; (2) PMA-induced NF-kB dependent gene expression was also inhibited by taxol; (3) IkBa phosphorylation and turnover were abrogated by taxol following PMA stimulation but not after TNF-a induction; (4) taxol decreased the level of PKC enzymatic activity in PMA stimulated cells; and (5) microtubule depolymerization induced by PMA was inhibited in the presence of taxol. In light of these observations, it appears that PMA stimulation of NF-kB activation is dependent, at least in part, on microtubule depolymerization which is sensitive to taxol-mediated stabilization of microtubules. This model is illustrated schematically in Figure  6 . On the other hand, TNF-a appears to signal through a microtubule-independent pathway not aected by taxol. Previous studies have also demonstrated that other terpenes such as helenalin (Lyss et al., 1997) and curcumin (Singh and Aggarwal, 1995) inhibit NF-kB induction, indicating that diterpenes like taxol may target microtubules and consequently in¯uence NF-kB activation. Many studies have shown that PMA exerts changes in the microtubule cytoskeleton through the activation of protein kinase C (Alexandrova et al., 1993; Bouron, 1997; Dwyer-Nield et al., 1996; Mangoura et al., 1995; Melamed et al., 1995; Moore et al., 1995) . Thus, stabilization of microtubules by taxol appears sufficient to block PMA-mediated microtubule depolymerization, reduce the amount of activated PKC in PMAstimulated cells and interfere with PMA-dependent phosphorylation of IkBa, a necessary prerequisite for IkBa degradation and activation of NF-kB DNA binding. Characterization of the PMA pathway leading to phosphorylation/degradation of IkBa and activation of NF-kB dependent gene activation is comprised of a PKC-mediated MAPK-dependent pathway (Seuerlein and Rozengurt, 1996; Young et al., 1996) . Phorbol ester-induced PKC is able to activate the MAP kinases ERK1/2 through direct activation of the c-Raf oncoprotein (Basu et al., 1996; Cai et al., 1997) . Following c-Raf activation, the MAPK/ERK kinase (MEK) is activated, in turn phosphorylating and activating the ERK1/2 cascade (Reszka et al., 1997; Payne et al., 1991; Zhang et al., 1994) . Of the many ERK substrates, one, the p90 ribosomal S6 kinase (pp90 rsk or RSK) has been ± 14) in the presence or absence of 5 mM taxol (30 min. pretreatment). IkBa was detected using a mouse monoclonal IkBa antibody (MAD10B) and phosphoserine 32 antibody speci®c for phosphorylated IkBa. (b) COS-7 cells were cultured in the presence of cycloheximide and either pretreated (lanes 7 ± 10) or untreated (lanes 3 ± 6) with 5 mM taxol 30 min prior to stimulation with PMA (100 ng/ml). Untreated and taxol treated controls are shown in lanes 1 and 2 respectively. IkBa was analysed by Western using the MAD10B antibody. (c) and (d) NIH3T3 cells were treated in a similar manner to COS-7 cells outlined in (a) and (b) respectively. Lane designations are also identical to (a) and (b). Speci®c proteins are indicated by the arrows implicated in IkBa phosphorylation (Bjorbaek et al., 1995; Sturgill et al., 1988) . Activated RSK interacts with IkBa and phosphorylates serine 32 exclusively (Schouten et al., 1997) . RSK may not be sucient to induce IkBa degradation alone and may require another kinase activity. However, transdominant mutants of RSK resulted in the complete abrogation of NF-kB activation in the presence of phorbol ester (Schouten et al., 1997) , providing evidence for the requirement of multiple IkBa kinases for induction of IkBa degradation. The newly characterized IkB Kinase complex (IKK) on the other hand phosphorylates both Ser 32 and Ser 36, although inducibility by PMA has not been assessed (Woronicz et al., 1997; Stancovski and Baltimore, 1997; Zandi et al., 1997; Regnier et al., 1997) . Therefore, modulation of upstream events in the PMA pathway by taxol could potentially block induction of other transcription factors that rely on the microtubule network for successful activation. An interesting possibility is that Figure 6 Schematic representation of inhibition of PMA-induced NF-kB activation by taxol. Taxol suppression of PKC activity blocks reorganization of the microtubule cytoskeleton, a possible RACK1 mediated process, and downstream activation of the MAPK pathway. Loss of either p90 rsk or possibly IKK leads to diminished IkBa phosphorylation and degradation. NF-kB nuclear translocation and gene activation are subsequently inhibited taxol may physically associate with IKK, pp90 rsk or another component of the signaling cascade. Based on the available data, it is unlikely that the interaction occurs directly with IKK, since this association would be expected to interfere with multiple signaling pathways, whereas the PMA but not the TNF pathway was blocked in the present study.
Previous studies indicate that NF-kB/IkBa colocalize to microtubules through an interaction between the signal response domain of IkBa and the dynein light chain subunit of the dynein microtubule motor complex (Crepieux et al., 1997) . Since latent NF-kB complexes are sequestered in the cytoplasm through their interaction with IkBa, it is not surprising that microtubule integrity may play an important role in regulating NF-kB activity by modulating its interaction with the microtubule network. Taxolstabilization of microtubules may therefore be sufficient to prevent PMA-stimulated IkBa phosphorylation, thus maintaining NF-kB in a latent cytoplasmic state. In this regard, pretreatment of cells with microtubule depolymerizing agents, nocodazole or colchicine, results in NF-kB activation (Rosette and Karin, 1995) .
The notion that taxol regulates NF-kB at the level of the microtubule interaction may account for part of this observation; taxol may also modulate PKC activity directly. In many cases, PMA stimulation results in the activation of a number of PKC isoforms, two of which ± PKC-a and PKC-z ± appear to be important in NF-kB induction (DiazMeco et al., 1996; Fogueira et al., 1996; Hyman et al., 1992; McGowan et al., 1996; Schonwesser et al., 1998) . Since an overall reduction in PKC activity was observed in taxol treated cells, this result may represent a speci®c decrease in the activity of taxolsensitive PKCs and not an attenuation of all PKC family members. Furthermore, colchicine activates PKC (Bouron, 1997), demonstrating that microtubule depolymerization enhances PKC activity.
Recently, a phorbol ester resistant U937 variant was shown to have diminished levels of microtubuleassociated PKCb 2 , due to the loss of microtubuleassociated PKC binding proteins (Kiley and Parker, 1997) . Interestingly, microtubule depolymerization with nocodazole reconstituted the normal phenotype and suggested a role for PKCb 2 association with microtubules as a requirement for normal microtubule reorganization. Given this observation, it is possible that taxol may also aect MT-associated PKC binding proteins in a similar manner. Taxol may deplete the available pool of microtubule associated PKC, thereby aecting downstream signals including IkBa phosphorylation. One candidate for such an associated protein is the PKC binding protein RACK1 (receptors for activated C-kinase) which is involved in anchoring activated PKCb to the cytoskeleton (Vani et al., 1997) and is required for its activation. In many cases, PMA induced expression of genes including human CDs, CD32, CD16, CD35 (Liu et al., 1996; Simms et al., 1996) , were speci®cally blocked by the addition of taxol.
Paradoxically, taxol elicits very distinct concentration dependent eects. At low concentrations, taxol elicits an inhibitory eect but at higher concentrations acts as a positive regulatory signal, especially in macrophage cells where taxol acts as an LPS-like activator in macrophage priming (Jun et al., 1995; Veis et al., 1996; Sweet and Humer, 1995) . Our results contradict ®ndings establishing taxol as an activator of NF-kB, particularly in cancer tissue-derived cell lines and macrophage cell lines. A major dierence between other studies and the present work is the relative concentration of taxol used; for example when used at a concentration of 5 mM, taxol suppressed IL-8 production (Shibata et al., 1996) but at 30 mM taxol activated IL-8 expression through induction of NF-kB and AP-1 (Lee et al., 1997) . NF-kB was likewise activated in the presence of 97 mM taxol (Das and White, 1997) and in macrophages, taxol concentrations in excess of 10 mM had stimulatory eects on iNOS and TNF-a secretion (Jun et al., 1995; Sweet and Humer, 1995) . Our preliminary experiments also demonstrated that higher concentrations of taxol had positive regulatory eects on NF-kB. These ®ndings indicate that taxol displays concentration dependent eects that modulate microtubule stabilization and cytopathic eects. Overall, the results presented in this study outline an intriguing association between microtubule architecture and the regulation of transcription factor activation, as well as highlight the need to de®ne other molecular consequences of taxol administration.
Materials and methods
Cell culture and reagents
Murine NIH3T3 ®broblasts (ATCC) and primate COS-7 cells were maintained in Dulbeco's Modi®ed Minimal Medium (DMEM) (GIBCO, Life Technologies Inc., Grand Island, NY, USA) supplemented with 5% calf serum (3T3) or 10% Fetal Bovine Serum (COS-7), 2 mM L-glutamine, and 10 mg/ml of gentamicin. Human embryonic kidney cells (293) were maintained in Alpha Modi®ed Minimal Medium (a-MEM) (GIBCO) supplemented with 10% Fetal Bovine Serum, 2 mM Lglutamine and 10 mg/ml gentamicin. PMA (stored at 100 mg/ml in ethanol), TNF-a (10 mg/ml in ddH 2 O), Nocodazole (10 mM in DMSO), were purchased from Sigma Chemical Co. (St Louis, MO, USA). Taxol (5 mM in DMSO) was purchased from ICN Pharmaceuticals, Inc (Costa Mesa, CA, USA). MG132 (10 mM in ethanol) was obtained from Biomol. The ®nal concentrations used for the following experiments are 100 ng/ml, PMA; 10 ng/ml, TNF-a; 20 mM, nocodazole; 5 mM, taxol; 10 mM, MG132.
Analysis of NF-kB-dependent gene expression
NIH3T3 cells were transfected with 10 mg of HIV enhancer (5'-GGGACTTTCCGCTGGGGACTTTCC-3') or HIV enhancer mutant (5'-CATGGTTTCCGCTGCATGGT TTCC-3') CAT reporter plasmid by lipofection (lipofectamine) as speci®ed by the manufacturer (Promega Inc.). At 48 h post transfection, cells were stimulated with PMA or TNF-a for various times in the presence or absence of taxol. Equal amounts of protein (20 ± 100 mg) were assayed for CAT activity for dierent hours depending on the level of inducible CAT expression. The percent of acetylation was determined by ascending thin layer chromatography as described previously (Garoufalis et al., 1994) . Inducibility of CAT expression was calculated as the relative foldinduction over that of untreated controls.
Electrophoretic mobility shift analysis
Nuclear extracts were prepared from NIH3T3 cells or 293 cells were treated with TNF-a or PMA in the presence or absence of taxol. Cells were washed in Buer A (10 mM HEPES, pH 7.9; 1.5 mM MgCl 2 ; 10 mM KCl; 0.5 mM dithiothreitol (DTT); and 0.5 mM phenylmethylsulfonyl uoride (PMSF)) and were resuspended in Buer A containing 0.1% NP-40. Cells were then chilled on ice for 10 min before centrifugation at 10 000 g. Pellets were then resuspended in Buer B (20 mM HEPES, pH 7.9; 25% glycerol; 0.42 M NaCl; 1.5 mM MgCl 2 ; 0.2 mM EDTA; 0.5 mM DTT; 0.5 mM PMSF; 5 mg/ml leupeptin; 5 mg/ml pepstatin; 0.5 mM spermidine; 0.15 mM spermine and 5 mg/ ml aprotinin). Samples were incubated on ice for 15 min before being centrifuged at 10 000 g. Nuclear extract supernatants were diluted with Buer C (20 mM HEPES, pH 7.9; 20% glycerol; 0.2 mM EDTA; 50 mM KCl; 0.5 mM DTT; and 0.5 mM PMSF). Nuclear extracts were subjected to EMSA by using a 32 P-labeled probe corresponding to the PRDII region of the IFN-b promoter (5'-GGGAAATTCCGGGAAATTCC-3'). The resulting protein-DNA complexes were resolved by 5% Tris-glycine gel and exposed to X-ray ®lm. To demonstrate the speci®city of protein-DNA complex formation, 125-fold molar excess of unlabeled oligonucleotide was added to the nuclear extract before adding labeled probe. For super shift analysis, rabbit polyclonal antibodies (3 ml) directed against human c-Rel, p105/p50, or p65 (Roulston et al., 1993) were incubated with nuclear extracts during the poly (dI:dC) step prior to addition of labeled probe. The resulting super shifts were analysed by EMSA.
Western blot analysis
To characterize IkBa turnover and phosphorylated form of IkBa, COS-7 cells were treated with TNF-a or PMA in the presence or absence of taxol. In some experiments cells were pretreated with 10 mM MG132 for 30 min prior to TNF-a or PMA induction. Cells were then washed with phosphate-buered saline and lysed in 10 mM Tris-Cl pH 8.0, 60 mM KCl, 1 mM EDTA, 1 mM dithiothreitol (DTT), 0.5% Nonidet P-40 (NP-40), 0.5 mM phenylmethysulfonyl¯uoride (PMSF), 10 mg/ml leupeptin, 10 mg/ml pepstatin and 10 mg/ml aprotinin. Equivalent amounts of whole cell extract (20 ± 40 mg) were subject to SDS ± polyacrylamide gel electrophoresis (SDS ± PAGE) in a 10% or 15% polyacrylamide gel. After electrophoresis, the proteins were transferred to Hybond transfer membrane (Amersham) in a buer containing 30 mM Tris, 200 mM glycine and 20% methanol for 1 h. The membrane was blocked by incubation in phosphate-buered saline (PBS) containing 5% dried milk for 1 h and then incubated overnight with N-terminal IkBa monoclonal antibody MAD 10B (Jaray et al., 1995) , Phospho-speci®c IkBa (Ser32) antibody (New England Biolabs, Inc) or anti-actin antibody (Sigma Co.) in 5% milk/PBS, at dilutions of 1 : 500 or 1 : 1000. These incubations were done at 48C overnight. After four 10 min washes with PBS, membranes were reacted with a peroxidase-conjugated secondary goat anti-rabbit or anti-mouse antibody (Amersham) at a dilution of 1 : 1000. The reaction was then visualized with the enhanced chemiluminescence detection system (ECL) as recommended by the manufacturer (Amersham Corp.).
PKC assays
NIH3T3 cells were grown to 80% con¯uence, incubated at 378C with PMA or TNF-a in the presence or absence of taxol. Whole cell extracts were prepared as described above except that 20 mM sodium vanadate was used to prevent dephosphorylation of the PKC substrate KRTLRR (Sigma), an epithelial growth factor (EGF)-derived peptide (Basu et al., 1990) . Using 50 mg of whole cell extract, reactions were incubated with 500 mM MOPS, pH 7, 100 mM MgCl 2 , 2.5 mg/ml BSA, 0.2 mCi [g 32 P]ATP and 1 mM of the PKC substrate. Reactions were incubated for 1 h at 378C. Background controls contained only lysis buer; the resulting value was subtracted from each experimental measurement. To limit the level of background labeling of endogenous substrates present in the whole cell extracts, reactions were stopped by precipitation of proteins with 50% trichloroacetic acid (TCA) and incubated on ice for 10 min. Due to the relatively small size of the EGF peptide, it remains soluble in TCA and can be eectively puri®ed. Cells were centrifuged at 14 000 g for 10 min and the supernatants were applied to phosphocellulose paper followed by three washes with 0.4% o-phosphoric acid and the level of phosphorylation determined. PKC activity was quanti®ed as the relative fold increase in [g 32 P]ATP incorporation into the PKC substrate.
Indirect immuno¯uorescence of cytoplasmic microtubules
Cells were seeded at a density of 10 5 cells in six well plates each containing glass coverslips. After treatment, coverslips were removed and washed twice with 16PBS. Cells were subsequently ®xed with 4% paraformaldehyde for 15 min followed by washing with PBS. Cells were permeabilized with 0.3% Triton X-100 in PBS for 5 min and washed three times with PBS and then blocked for 30 min in 5% BSA and incubated with mouse monoclonal tubulin antibody (Sigma) (dilution 1 : 250) for 2 h. After incubation with the primary antibody, cells were washed numerous times with 16PBS and incubated for 1 h with rabbit-FITC (1 : 250 dilution) conjugated antibody (Jackson Laboratories) followed by three washes with 16PBS. Microscopy was performed using a Leitz¯uorescence microscope (Aristoplan) at a magni®cation of 4006.
